The role of the FKBP51–Hsp90 complex in Alzheimer’s disease: An emerging new drug target

Xavier Jeanne, Zsolt Török, László Vigh, Chrisostomos Prodromou · 2024

Read The role of the FKBP51–Hsp90 complex in Alzheimer’s disease: An emerging new drug target by Xavier Jeanne, Zsolt Török, László Vigh, Chrisostomos Prodromou (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11664163.txt.

Description

Xavier Jeanne and colleagues review a chaperone partnership that bends tau toward tangles, and the drug lead that breaks it up, in this paper from twenty twenty-four. Ageing unbalances the cell's protein-folding crews. One co-chaperone, FKBP51, rises with age and rises further in Alzheimer disease, where it partners with the chaperone Hsp90 to twist tau into its disease-prone form.

Twisted tau takes phosphate marks more readily and clumps. The authors' hypothesis places this partnership downstream of amyloid plaques: plaque damage induces FKBP51, which then unleashes tauopathy. Supporting the target, the complex's structure is now solved, and a small molecule, LA1011, was shown to disrupt it and to prevent neurodegeneration in Alzheimer-model mice. The review assembles the case for drugging the FKBP51-Hsp90 complex before tau's cascade starts.

Catalog record

CREATORXavier Jeanne, Zsolt Török, László Vigh, Chrisostomos Prodromou
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11664163

Browse the full library · About the Tower of Babel